Insights

Navigating the current healthcare legislative landscape

Infusion errors don’t stay in the chair: understanding the ripple effects

The vital role of digital automation in advancing infusion management

Bringing data-driven clarity to provider coding patterns

Why drug billing blind spots lead to missed revenue for practices

How InfoDive® brings visibility and accuracy into the payment process

2026 MIPS Final Rule: What’s changing in Quality, Cost, & MVP reporting

Q&A with the Cencora Office of U.S. Public Policy and Advocacy

Establishing a theranostics center and preparing for expanding indications

MIPS 2026 Final Rule: What practices need to know

A layered approach to PBM audit support for medically integrated dispensing programs

Your practice’s year-end wellness check – Part 1

Your practice’s year-end wellness check – Part 3

A practical guide to PBM audits: Reducing risk in medically integrated dispensing

Is your Accounts Receivable process holding you back?

What you need to know about understanding the MIPS Quality measures types

CMS wants your input on the 2026 Proposed Rule for MIPS

Access, understand, improve: Turn your data into decisions, and decisions into action

Exploring Non-drug Related Services in Healthcare

Working with the MIPS Consulting team can offer your practice valuable assistance

We talk about ‘actionable insights’ – but what does that actually mean?

MIPS readiness – have you created your HARP account?

Important dates for the Quality Payment Program

How routine coding audits can protect your practice

Advancing patient safety in infusion therapy

Are you missing critical insights about your practice’s performance?

Q&A with the Cencora Office of U.S. Public Policy and Advocacy

Unlocking the potential of benchmarking for greater productivity and financial success

The vital role of a distributor in the U.S. pharmaceutical supply chain

Boosting practice success by unlocking the value of RVUs

Simplifying infusion management in your practice

Understanding the impact of the Medicare Physician Fee Schedule on your practice

Are you ready to report on MVPs?

Looking ahead for MIPS in 2025 – what has changed, what hasn’t

Q&A with the Cencora Office of U.S. Public Policy and Advocacy

Are your marketing efforts working for your practice?

Uncovering lost revenue in your practice

Drive results with InfoDive® business coaches

Q&A: 2025 Medicare Physician Fee Schedule Proposed Rule

Are you ready for the MVPs?

2025 MIPS Proposed Rule is trying to make it easier on practices - Part 2

2025 MIPS Proposed Rule is trying to make it easier on practices

Q&A: The Medicare Access and CHIP Reauthorization Act (MACRA)

Understanding seasonal vaccines efforts far beyond the vaccination season

Q&A: The Seniors’ Access to Critical Medications Act of 2023 (H.R. 5526/S. 3458)

Cost Analytics Service essential for planning for your practice

How can the MIPS Consulting team help your practice?

MIPS reporting is essential for practice’s bottom line

Treatment protocols - helpful for patient outcomes and potentially faster reimbursement to your practice

Navigating the CMS' CY 2024 proposed rule: part 2

Navigating the CMS CY 2024 proposed rule: part 1

Managing cost is a key driver for value-based care

MIPS versus Advanced APMs – highlights of the different models, and what it could mean for your practice

What does your practice need to do to participate in clinical trials or research studies?

Q&A with the AmerisourceBergen Office of Government Affairs and Public Policy (AB GA&P)

What matters most: The value of solidarity and innovation in specialty practice partnerships

Roundtable discussion: How payer models and metrics can contribute to more equitable care

Physician Practices

Addressing disparities in cancer care

Pharmacies

3 ways your distributor can help you prepare for DSCSA compliance

Government Affairs Q&A: The latest on Medicare Part B

Pharmacies

DSCSA: Are you ready for November 2024?

What matters most: Building meaningful distribution partnerships

Physician Practices

Physician fee cuts and policy updates: What's at stake for practices in 2023

Physician Practices

Seven questions about biosimilars

Physician Practices

What matters most: Understanding our customer's experience

Clinically integrated oncolytic dispensing: The next frontier in cancer care

Policy updates: From the Inflation Reduction Act to the Enhancing Oncology Model

Physician Practices

Evolving with our customers: Putting patients first through specialty distribution

Physician Practices

Q&A with the AmerisourceBergen Office of Government Affairs and Public Policy (AB GA&P)

Physician Practices

Navigating buy-and-bill: What every practice should monitor and how data analytics can help

Is your practice monitoring physician productivity?

Physician Practices

Q&A: The dangers of pending Medicare cuts and what practices can expect in 2022

Physician Practices

Community oncology practices build more equitable access and outcomes

Protecting your practice from cyberthreats

New Provider Relief Fund Distributions

Physician Practices

How specialty practices can prepare for coming changes to reimbursement

HHS Provider Relief Fund reporting deadline approaching

US Department of Labor's OSHA issues Emergency Temporary Standard to protect healthcare workers from coronavirus

The AmerisourceBergen Foundation sponsors "A Financial Guide to COVID-19"

HHS issues revised notice of reporting requirements and reporting timeline for recipients of Provider Relief Fund payments

SBA halts applications for PPP loans

How does your practice prepare to meet your security standards?

Physician Practices

Supporting flu vaccine access

Potential cyber risks - why practices are targeted

Physician Practices

Healthcare payer trends in 2021

CMS has updated Open Payments data

2021 evaluation and management coding updates

What practices need to know about the Most Favored Nation rule

Health Systems

Biosimilars: Patents, policy, and reimbursement

The Vital Role of Community Practices in Delivering Care Through a Pandemic

Physician Practices

The early impact of COVID-19 on specialty practices

Physician Practices

How to thrive with telemedicine

Physician Practices

Roundtable: The early impact of COVID-19 on community practices

Physician Practices

The now normal, part 3: Proactive communications for practice success

Physician Practices

The now normal, part 2: Getting your practice future-ready

Physician Practices

The Vital Role of Community Practices in Delivering Care Through a Pandemic

Physician Practices

The now normal, part 1: Data analysis for smart business decisions

Physician Practices

How Community and Specialty Physician Practices Are Confronting COVID-19 Challenges

Physician Practices

Roundtable: The road ahead for community practices

Physician Practices

COVID-19 Resources

Physician Practices

Tips for Practices to Keep Patients and Staff Healthy

Physician Practices

How COVID-19 is Altering Telehealth

Physician Practices

Roundtable: Working together in response to COVID-19

Physician Practices

Cybersecurity and Working Virtually During the Pandemic

Navigating Inventory Management in the Oncology Practice

Physician Practices

Inventory Management Technology as the Hub of a Fully Integrated Specialty Practice Solution: Part 3

Physician Practices

Inventory Management Technology as the Hub of a Fully Integrated Specialty Practice Solution: Part Two

Physician Practices

Inventory Management Technology as the Hub of a Fully Integrated Specialty Practice Solution: Part One

Physician Practices

How Independent Oncology Practices can Increase Referrals

Manufacturers

Understanding Blockchain for DSCSA Compliance

Physician Practices

Helping Specialty Practices Bridge the Clinical Research Gap

Physician Practices

How Successful Oncology Practices are Continuing to Prosper Through Innovation

Physician Practices

Five Ways to Stop Practice Profit Leaks

Health Systems

Cancer Care at a Crossroads

Physician Practices

The Metamorphosis of a Community Oncology Practice

Physician Practices

Adherence to Oral Oncolytics Requires a Clinically Integrated Approach to Specialty Pharmacy